Nephros (NEPH) Cash from Operations Growth (1y) (2011 - 2026)
Nephros (NEPH) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 48.31% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 428.92% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -39.59% |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -4.24% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -29.98% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 90.02% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -751.72% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 186.74% |
| 10 | Nephros | 40.88 Mn | 36.86 Mn | 2.99 Mn | -618.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -618.94% |
| Dec 31, 2025 | -85.81% |
| Sep 30, 2025 | 115.89% |
| Jun 30, 2025 | 298.40% |
| Mar 31, 2025 | 147.92% |
| Dec 31, 2024 | 577.66% |
| Sep 30, 2024 | -204.18% |
| Jun 30, 2024 | -321.68% |
| Mar 31, 2024 | -343.48% |
| Dec 31, 2023 | -40.00% |
| Sep 30, 2023 | 451.76% |
| Jun 30, 2023 | 121.08% |
| Mar 31, 2023 | 115.36% |
| Dec 31, 2022 | 41.79% |
| Sep 30, 2022 | 81.32% |
| Jun 30, 2022 | -816.24% |
| Mar 31, 2022 | -3,167.27% |
| Dec 31, 2021 | 78.05% |
| Sep 30, 2021 | 49.92% |
| Jun 30, 2021 | 93.20% |